Trinity Capital Inc. Provides $15 Million in Growth Capital to restor3d

Rhea-AI Summary

Trinity Capital (NASDAQ: TRIN) has committed $15 million in growth capital to restor3d, a company specializing in 3D-printed, patient-specific medical devices. This investment aims to support restor3d's innovation in orthopedic implants and facilitate its expansion into new markets. restor3d utilizes advanced 3D printing, AI-based planning, and digital health solutions to optimize patient outcomes. Trinity's Managing Director, Life Sciences, Lauren Cosentino, emphasized the company's leading role in customized orthopedic implants. restor3d's CEO, Kurt Jacobus, highlighted the partnership's potential to scale the business and enhance surgical outcomes.

Positive

• Commitment of $15 million in growth capital to restor3d.
• Supports restor3d's expansion into new markets.
• Emphasizes restor3d's role in customized orthopedic implants.
• Utilization of advanced 3D printing, AI-based planning, and digital health solutions.
• Potential to enhance patient care and surgical outcomes.

Negative

• Potential debt increase for restor3d.
• Risk of over-reliance on a single technology platform.

PHOENIX, June 5, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the commitment of $15 million in growth capital to restor3d, a 3D printing, patient specific medical device company.

restor3d enhances patient care and meets surgeons' needs by providing solutions tailored to patients' unique anatomies, enabling precise repair, reconstruction, and restoration. The company holds proprietary expertise in advanced 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes.

"restor3d is at the forefront of innovation in the customized orthopedic implant industry with its unique patient specific 3D printed technologies," said Lauren Cosentino, Managing Director, Life Sciences at Trinity. "We look forward to working with restor3d's leadership team and supporting the company's continued growth." 

The new debt facility from Trinity will allow restor3d to continue its product innovation and expansion into new markets.

"We are thrilled to partner with Trinity as we continue to scale our business and bring our innovative, patient specific medical devices to more surgeons and patients worldwide," said Kurt Jacobus, Chief Executive Officer of restor3d. "This investment underscores the immense potential of our technology to transform patient care and drive better surgical outcomes."

About Trinity Capital Inc.

Trinity Capital Inc. (Nasdaq: TRIN), an internally managed business development company, is a leading provider of diversified financial solutions to growth-stage companies with institutional equity investors. Trinity Capital's investment objective is to generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equipment financings and equity-related investments. Trinity Capital believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience and track record in lending to growth stage companies. For more information, please visit the Company's website at www.trinitycap.com.

About restor3d, Inc.

restor3d is a world leader in patient specific musculoskeletal implants and driven by the belief that every patient deserves personalized care. The company holds proprietary expertise in 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes. Alongside its customers, restor3d is reimagining the musculoskeletal reconstruction landscape. More information is available at www.restor3d.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-15-million-in-growth-capital-to-restor3d-302163928.html

SOURCE Trinity Capital Inc.

FAQ

What is the amount of growth capital provided by Trinity Capital to restor3d?

Trinity Capital has committed $15 million in growth capital to restor3d.

What does restor3d specialize in?

restor3d specializes in 3D-printed, patient-specific medical devices.

How will the $15 million investment benefit restor3d?

The investment will support product innovation and expansion into new markets.

What technologies does restor3d utilize?

restor3d uses advanced 3D printing, AI-based planning, and digital health solutions.

What is the stock symbol for Trinity Capital?

The stock symbol for Trinity Capital is TRIN.

What impact could the partnership with Trinity Capital have on restor3d?

The partnership could help restor3d scale its business and enhance surgical outcomes.